Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
US10413620B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 15, 2015 |
| Grant date | Sep 17, 2019 |
| Priority date | — |
| Expiry date | Sep 15, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The presently disclosed subject matter provides compositions and kits comprising light-emitting versions of the monoclonal antibody to C3d (mAB 3d29) for imaging and methods of use thereof for detecting infectious and inflammatory cells in vivo. The presently disclosed subject matter also provides methods for detecting and/or monitoring a Mycobacterium tuberculosis (M. tuberculosis) infection in a subject, as well as methods of treating a M. tuberculosis infection in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.